RareDiseasesNews.net

Rare diseases Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Castleman’s disease"

The FDA ( Food and Drug Administration ) has approved Sylvant ( Siltuximab ) for the treatment of patients with multicentric Castleman’s disease ( MCD ) who are human immunodeficiency virus ( HIV ) ne ...